Mumbai: Aurobindo Pharma today said it has received US regulatory approval for manufacturing and marketing of Fluconazole tablets, used as an anti-fungal drug.
In a filing to the Bombay Stock Exchange, Aurobindo Pharma said it has received approval from the US Food and Drug Administration (USFDA) for Fluconazole tablets, in strengths of 0.25, 0.5, 1, 2, 3 and 4 mg.
Fluconazole is an anti-fungal drug used in the treatment and prevention of fungal infections.
This approval takes the number of Abbreviated New Drug Application approval for Aurobindo Pharma to 81, it said.
Last week, the company had received approval for Fluconazole tablets in 50, 100, 150 and 200 mg variants.
Shares of Aurobindo Pharma were trading at Rs 195.50, up 0.26 per cent in afternoon trade on the BSE.